Viewing Study NCT01531361


Ignite Creation Date: 2025-12-24 @ 12:09 PM
Ignite Modification Date: 2025-12-28 @ 12:07 PM
Study NCT ID: NCT01531361
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2012-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module